📖

GTX-102 (GeneTx/Ultragenyx) — Angelman Syndrome Phase 1/2 Trial

wiki page Created: 2026-04-02 13:40:08 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-clinical-trials-gtx102-angelman-syn

Related Entities

clinical-trials-gtx102-angelman-syndrome-phase-1-2

Metadata

slug	clinical-trials-gtx102-angelman-syndrome-phase-1-2
entity_type	clinical
kg_node_id	None

🌍 Provenance Graph 1 nodes, 0 edges

No provenance edges found

Linked Artifacts (23)

related🧫Macroautophagy Dysfunction in PD - Experiment Design70%

related🧫Macroautophagy Dysfunction in PD - Experiment Design70%

mentions🧪Stress Granule Phase Separation Modulators50%

mentions🧪Phase-Separated Organelle Targeting50%

related🔬What are the mechanisms underlying microglia-astrocyte cross50%

related🔬What are the mechanisms underlying rna binding protein dysre50%

related🔬What are the mechanisms underlying tdp-43 phase separation t50%

related🔬What are the mechanisms underlying microglia-astrocyte cross50%

related🔬What are the mechanisms underlying rna binding protein dysre50%

related🔬TDP-43 undergoes liquid-liquid phase separation that becomes50%

related🧪Excitatory Neuron Vulnerability via SLC17A7 Downregulation50%

related🧪SASP-Mediated Cholinergic Synapse Disruption50%

related🧪Synaptic Phosphatidylserine Masking via Annexin A1 Mimetics50%

related🧪Sleep Spindle-Synaptic Plasticity Enhancement50%

related🧪Trans-Synaptic Adhesion Molecule Modulation50%

related🧪Mitochondrial-Lysosomal Contact Site Engineering50%

related🧪Lysosomal Membrane Repair Enhancement50%

related🧪Lysosomal Calcium Channel Modulation Therapy50%

related🧪Lysosomal Enzyme Trafficking Correction50%

mentions🔬What are the mechanisms underlying tdp-43 phase separation t40%

mentions🔬TDP-43 undergoes liquid-liquid phase separation that becomes40%

related🧪Stress Granule Phase Separation Modulators40%

related🧪Phase-Separated Organelle Targeting40%